Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the eight brokerages that are currently covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation, four have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $18.86.
A number of research firms recently commented on SBRA. Truist Financial downgraded Sabra Health Care REIT from a “buy” rating to a “hold” rating and cut their price target for the company from $18.00 to $17.00 in a report on Friday, January 17th. Citizens Jmp upgraded Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 7th. Mizuho reissued a “neutral” rating and issued a $20.00 price target on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. Finally, JMP Securities raised shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price objective for the company in a research note on Tuesday, January 7th.
Get Our Latest Stock Analysis on Sabra Health Care REIT
Hedge Funds Weigh In On Sabra Health Care REIT
Sabra Health Care REIT Stock Performance
SBRA opened at $16.39 on Thursday. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.32 and a quick ratio of 4.16. The stock has a market cap of $3.90 billion, a P/E ratio of 30.93, a P/E/G ratio of 1.97 and a beta of 1.25. Sabra Health Care REIT has a 1-year low of $13.31 and a 1-year high of $20.03. The stock’s 50 day simple moving average is $16.78 and its 200 day simple moving average is $17.62.
Sabra Health Care REIT (NASDAQ:SBRA – Get Free Report) last posted its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share for the quarter, meeting the consensus estimate of $0.36. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. The firm had revenue of $182.35 million during the quarter, compared to the consensus estimate of $178.01 million. As a group, equities analysts anticipate that Sabra Health Care REIT will post 1.45 EPS for the current fiscal year.
Sabra Health Care REIT Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Investors of record on Friday, February 14th will be issued a $0.30 dividend. The ex-dividend date is Friday, February 14th. This represents a $1.20 annualized dividend and a yield of 7.32%. Sabra Health Care REIT’s dividend payout ratio is currently 226.42%.
About Sabra Health Care REIT
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Featured Articles
- Five stocks we like better than Sabra Health Care REIT
- Do ETFs Pay Dividends? What You Need to Know
- Buffett’s on the Sidelines – Should You Follow?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- What Are Dividend Achievers? An Introduction
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.